A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma

Disease Sites:

Not Available

Staging:

Phase III

Age Group:

Adults

Therapies:

Chemotherapy - cytotoxic, Mol. targeted/Immunotherapy/Biologics

Drugs:

Blinded Drug, Gemcitabine, Nab-Paclitaxel

Principal Investigator(s):

Cardin, Dana

Participating Institutions:

Vanderbilt University

Open Date:

05-23-2025

Trial Type:

Treatment

Protocol ID:

VICC-DTGIT24162

National Clinical Trial ID:

NCT06608927

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available